This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 TT Yoshikawa (2000) Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis 30, 931–933.
2 G Gavazzi & KH Krause (2002) Ageing and infection. Lancet Infect Dis 2, 659–666.
6 K Goodwin , C Viboud & L Simonsen (2006) Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24, 1159–1169.
7 JE McElhaney (2005) The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine 23, Suppl. 1, S10–S25.
8 PV Targonski , RM Jacobson & GA Poland (2007) Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine 25, 3066–3069.
9 KL Nichol (2003) The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 21, 1769–1775.
10 J Nikolich-Zugich (2008) Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol 8, 512–522.
11 AD Delpedro , MJ Barjavel , Z Mamdouh , (1998) Signal transduction in LPS-activated aged and young monocytes. J Interferon Cytokine Res 18, 429–437.
12 JA McLachlan , CD Serkin , KM Morrey-Clark , (1995) Immunological functions of aged human monocytes. Pathobiology 63, 148–159.
14 J Mysliwska , A Mysliwski , P Romanowski , (1992) Monocytes are responsible for depressed natural killer (NK) activity in both young and elderly low NK responders. Gerontology 38, 41–49.
15 R Solana & E Mariani (2000) NK and NK/T cells in human senescence. Vaccine 18, 1613–1620.
16 G Riezzo , M Chiloiro & F Russo (2005) Functional foods: salient features and clinical applications. Curr Drug Targets Immune Endocr Metabol Disord 5, 331–337.
17 PJ Jones & KA Varady (2008) Are functional foods redefining nutritional requirements? Appl Physiol Nutr Metab 33, 118–123.
18 HS Gill & F Guarner (2004) Probiotics and human health: a clinical perspective. Postgrad Med J 80, 516–526.
21 M Hickson , AL D'Souza , N Muthu , (2007) Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 335, 80.
25 AC Ouwehand , N Bergsma , R Parhiala , (2008) Bifidobacterium microbiota and parameters of immune function in elderly subjects. FEMS Immunol Med Microbiol 53, 18–25.
26 A Klein , U Friedrich , H Vogelsang , (2008) Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp. lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Eur J Clin Nutr 62, 584–593.
27 M Kaila , E Isolauri , E Soppi , (1992) Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 32, 141–144.
28 D Bunout , G Barrera , S Hirsch , (2004) Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. J Parenter Enteral Nutr 28, 348–354.
29 M de Vrese , P Winkler , P Rautenberg , (2005) Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr 24, 481–491.
31 PJ Aggett , JM Antoine , NG Asp , (2005) PASSCLAIM: consensus on criteria. Eur J Nutr 44, Suppl. 1, i5–i30.
33 M Haarman & J Knol (2006) Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl Environ Microbiol 72, 2359–2365.
36 JM Graat , EG Schouten & FJ Kok (2002) Effect of daily vitamin E and multivitamin–mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA 288, 715–721.
38 MD Parra , BE Martínez de Morentin , JM Cobo , (2004) Daily ingestion of fermented milk containing Lactobacillus casei DN114001 improves innate-defense capacity in healthy middle-aged people. J Physiol Biochem 60, 85–91.
39 A Marcos , J Warnberg , E Nova , (2004) The effect of milk fermented by yogurt cultures plus Lactobacillus casei DN-114 001 on the immune response of subjects under academic examination stress. Eur J Nutr 43, 381–389.
41 K Hatakka , E Savilahti , A Ponka , (2001) Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322, 1327.
43 NJ Cooper , AJ Sutton , KR Abrams , (2003) Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 326, 1235.
44 FG Hayden (2004) Rhinovirus and the lower respiratory tract. Rev Med Virol 14, 17–31.
45 TG Wald , P Shult , P Krause , (1995) A rhinovirus outbreak among residents of a long-term care facility. Ann Intern Med 123, 588–593.
46 R Oozeer , A Leplingard , DD Mater , (2006) Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk. Appl Environ Microbiol 72, 5615–5617.
48 V Rochet , L Rigottier-Gois , F Levenez , (2008) Modulation of Lactobacillus casei in ileal and fecal samples from healthy volunteers after consumption of a fermented milk containing Lactobacillus casei DN-114 001Rif. Can J Microbiol 54, 660–667.
52 P Pujol , J Huguet , F Drobnic , (2000) The effect of fermented milk containing Lactobacillus casei on the immune response to exercise. Sports Med Training and Rehab 9, 209–223.
53 E Tiollier , M Chennaoui , D Gomez-Merino , (2007) Effect of a probiotics supplementation on respiratory infections and immune and hormonal parameters during intense military training. Mil Med 172, 1006–1011.
54 T Boge , M Rémigy , S Vaudaine , (2009) A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine .
55 PM Sherman , JC Ossa & K Johnson-Henry (2009) Unraveling mechanisms of action of probiotics. Nutr Clin Pract 24, 10–14.
57 I Ingrassia , A Leplingard & A Darfeuille-Michaud (2005) Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells. Appl Environ Microbiol 71, 2880–2887.
58 N Parassol , M Freitas , K Thoreux , (2005) Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Res Microbiol 156, 256–262.
59 J Wehkamp , J Harder , K Wehkamp , (2004) NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 72, 5750–5758.